Phase I study of adjuvant gemcitabine or S-1 in patients with biliary tract cancers undergoing major hepatectomy: KHBO1003 study
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phase I study of adjuvant gemcitabine or S-1 in patients with biliary tract cancers undergoing major hepatectomy: KHBO1003 study
Authors
Keywords
Biliary tract cancer, Major hepatectomy, Adjuvant chemotherapy, Gemcitabine, S-1
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 74, Issue 4, Pages 699-709
Publisher
Springer Nature
Online
2014-07-29
DOI
10.1007/s00280-014-2543-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1004)
- (2014) Masanori Toyoda et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Evaluation of safety parameters and changes in serum concentration in liver transplant recipients treated with doxorubicin during the anhepatic period
- (2013) Shogo Kobayashi et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A multicenter phase II study of S-1 for gemcitabine-refractory biliary tract cancer
- (2013) Eiichiro Suzuki et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Randomized phase II study of gemcitabine plus S-1 versus S-1 in advanced biliary tract cancer: A Japan Clinical Oncology Group trial (JCOG 0805)
- (2013) Chigusa Morizane et al. CANCER SCIENCE
- A single-center analysis of the survival benefits of adjuvant gemcitabine chemotherapy for biliary tract cancer
- (2013) Kenya Yamanaka et al. International Journal of Clinical Oncology
- Chemotherapy for cholangiocarcinoma: An update
- (2013) Natalia Ramírez-Merino World Journal of Gastrointestinal Oncology
- Effect of Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid or Gemcitabine vs Observation on Survival in Patients With Resected Periampullary Adenocarcinoma
- (2012) John P. Neoptolemos et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Role of chemotherapy in treatments for biliary tract cancer
- (2012) Junji Furuse et al. Journal of Hepato-Biliary-Pancreatic Sciences
- Adjuvant chemotherapy for resectable biliary tract cancer: current status and future direction
- (2012) Masaru Konishi Journal of Hepato-Biliary-Pancreatic Sciences
- Treatment of borderline cases for curative resection of biliary tract cancer
- (2011) Shogo Kobayashi et al. JOURNAL OF SURGICAL ONCOLOGY
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
- (2010) Juan Valle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adjuvant Gemcitabine Plus S-1 Chemotherapy Improves Survival After Aggressive Surgical Resection for Advanced Biliary Carcinoma
- (2009) Yoshiaki Murakami et al. ANNALS OF SURGERY
- A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer
- (2009) H Ueno et al. BRITISH JOURNAL OF CANCER
- Gemcitabine-Based Adjuvant Chemotherapy Improves Survival After Aggressive Surgery for Hilar Cholangiocarcinoma
- (2009) Yoshiaki Murakami et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Impact of postoperative irradiation after non-curative resection of hilar biliary cancer
- (2009) Shogo Kobayashi et al. JOURNAL OF SURGICAL ONCOLOGY
- Randomized Phase III Trial of Adjuvant Chemotherapy with Gemcitabine versus S-1 in Patients with Resected Pancreatic Cancer: Japan Adjuvant Study Group of Pancreatic Cancer (JASPAC-01)
- (2008) A. Maeda et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started